You searched for metabolic diseases - Page 28 of 64

In Depth 11 Dec 2024

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

…also contribute to immune dysfunction in inflammatory and autoimmune diseases, and targeting sialoglycans and/or their receptors could have therapeutic potential in suppressing the immune system in these diseases. In addition,…

December 11, 2024 - 9 minutesmins - By Willow Shah-Neville

News and Trends 11 Jan 2018

German Biotech Gets FDA Approval to Start an Ulcerative Colitis Phase II Study

…II trials for both ulcerative colitis and Crohn’s disease (CD). Dihydroorotatede hydrogenase (DHODH) inhibition causes metabolic stress in active immune cells, leading to their altered function or apoptosis. With diseases…

January 11, 2018 - 3 minutesmins - By Alex Dale

Best in Biotech 16 Jan 2024

Five biotech companies taking Florida by storm

…drive the state’s biotech scene. Table of contents AIM ImmunoTech AIM ImmunoTech is focused on researching and developing therapies to treat multiple types of cancers, immune disorders, and viral diseases….

January 16, 2024 - 6 minutesmins - By Willow Shah-Neville

Podcast 1 Mar 2024

The final chapter in genomic medicines?

…company be focusing on diseases of the liver. “Fortunately, we were able to scour the landscape of genetic defects of the liver and determine four or five diseases which are…

March 1, 2024 - 8 minutesmins - By Jim Cornall

News and Trends 20 Jun 2023

NodThera announces positive inflammatory disease data

…highly validated drug target that plays a pivotal role in controlling inflammatory diseases. The differentiated design characteristics of each candidate enabled them to penetrate different areas of the brain for…

June 20, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 27 Mar 2020

Evox Therapeutics Receives up to €800M from Takeda To Tackle Rare Diseases

The Japanese pharmaceutical company Takeda has struck a deal worth up to €803M with UK biotech Evox Therapeutics to develop rare disease treatments delivered to cells via nanocapsules called exosomes….

March 27, 2020 - 3 minutesmins - By Laura Cowen

Best in Biotech 8 Jun 2023

Six companies that have made their name in the cardiovascular space

…of treatments within the cardiovascular space, and a cure for cardiovascular diseases may even be on the horizon after Moderna recently stated that vaccines for this group of diseases could…

June 8, 2023 - 7 minutesmins - By Willow Shah-Neville

Best in Biotech 4 Apr 2023

6 biotechs that have stepped into the protein degradation space

…interactions. The company acknowledges that there is a need for a novel approach to target CNS diseases such as Alzheimer’s and Parkinson’s diseases as they are caused by an accumulation…

April 4, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 26 Apr 2023

aVaxziPen’s needle-free vaccine yields positive data across multiple diseases

aVaxziPen, a biotech company developing a novel needle-free vaccine delivery platform, presented data at the World Vaccine Congress (WVC) in Washington, U.S., recently. The company presented a poster entitled, “Needle-free,…

April 26, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 12 Mar 2018

A Flick of a Switch Can Cause Age-Related Brain Deterioration

…the epigenome in these diseases, the research also supports Oryzon’s approach that removes epigenetic modifications that are linked to the onset of diseases like Alzheimer’s. Images via Andrea Danti, whiteMocca…

March 12, 2018 - 3 minutesmins - By Alex Dale

In Depth 15 Dec 2022

To avoid stagnation, the EU must refine its ATMP regulation

…reference networks (ERNs) to make it easier to diagnose and fight rare diseases, including those that could be treated with ATMPs. Image/Shutterstock EU HTA regulations aren’t flexible enough The industry…

December 15, 2022 - 8 minutesmins - By Jonathan Smith

janssen microbiome inflammatory bowel disease

News and Trends 13 Dec 2018

Janssen Recruits Microbiome Company to Fight Inflammatory Bowel Disease

…hot topic for researching inflammatory diseases since imbalances in gut microbes are linked to the development of an exaggerated immune response in these diseases. Furthermore, the microbiome has a role…

December 13, 2018 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

German Biotech Gets FDA Approval to Start an Ulcerative Colitis Phase II Study

Five biotech companies taking Florida by storm

The final chapter in genomic medicines?

NodThera announces positive inflammatory disease data

Evox Therapeutics Receives up to €800M from Takeda To Tackle Rare Diseases

Six companies that have made their name in the cardiovascular space

6 biotechs that have stepped into the protein degradation space

aVaxziPen’s needle-free vaccine yields positive data across multiple diseases

A Flick of a Switch Can Cause Age-Related Brain Deterioration

To avoid stagnation, the EU must refine its ATMP regulation

Janssen Recruits Microbiome Company to Fight Inflammatory Bowel Disease

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!